Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Prelude Therapeutics Inc | EVP, Chief of Clinical Affairs | Employee Stock Option (right to buy) | 90K | Feb 15, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PRLD | Prelude Therapeutics Inc | Feb 15, 2022 | 1 | $0 | 4 | Feb 17, 2022 | EVP, Chief of Clinical Affairs |
PRLD | Prelude Therapeutics Inc | Dec 15, 2021 | 6 | -$37.4K | 4 | Dec 17, 2021 | EVP, Chief of Clinical Affairs |
PRLD | Prelude Therapeutics Inc | Nov 16, 2021 | 4 | -$87.1K | 4 | Nov 18, 2021 | EVP, Chief of Clinical Affairs |
PRLD | Prelude Therapeutics Inc | Jul 20, 2021 | 1 | $0 | 4 | Jul 22, 2021 | EVP, Chief of Clinical Affairs |